Similarly, cancer-associated fibroblasts (CAF) in the tumor microenvironment promote the progression of gastric cancer through IL-6/JAK2/STAT3 signaling and achieve a targeted therapeutic effect on gastric cancer through the action of IL-6 on stromal fibroblasts [62]. This evidence concerns the gene JAK2 and gastric cancer.